Specifically, when separately evaluating in utero exposure to two androgen receptor antagonists—either vinclozolin or procymidone—Rider et al. [78] reported that vinclozolin alone induced hypospadias in 10% of male rats while procymidone alone had no effect male reproductive tract malformations (hypospadias or vaginal pouch development). Here, AR is linked to hypospadias.